C-Reactive Protein-to-Albumin Ratio as a Predictive Indicator for Evaluating Tolerability in S-1 Adjuvant Chemotherapy after Curative Surgery for Pancreatic Cancer: An External Validation Cohort Study

S-1 in adjuvant chemotherapy (AC) administration after pancreatic cancer (PC) surgery has been standardized in Japan. The Ehime study confirmed that a postoperative higher C-reactive protein-to-albumin ratio (CAR) value predicted the risk of adverse event (AE)-related S-1 non-completion as an AC in...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancers 2024-10, Vol.16 (19), p.3372
Hauptverfasser:	Funamizu, Naotake, Mori, Shozo, Sakamoto, Akimasa, Iwata, Miku, Shine, Mikiya, Ito, Chihiro, Uraoka, Mio, Ueno, Yoshitomo, Tamura, Kei, Umeda, Yuzo, Aoki, Taku, Takada, Yasutsugu
Format:	Artikel
Sprache:	eng
Schlagworte:	Adjuvant treatment Albumin Antigens Blood tests C-reactive protein Cancer Cancer therapies Care and treatment Chemotherapy Complications and side effects Demographics Drug dosages Health aspects Hospitals Measurement Medical prognosis Multivariate analysis Nutritional status Pancreatic cancer Patients Prognosis Proteins Risk factors Serum albumin Statistical analysis Surgery Surveillance
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!